These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 26799139

  • 41. [Iron overload disease: recent findings].
    Licata A, Brucato V, Di Marco V, Barbaria F, Craxì A.
    Ann Ital Med Int; 2004; 19(3):145-54. PubMed ID: 15529941
    [Abstract] [Full Text] [Related]

  • 42. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S, Marconi S, Sikorska K, Naeem R, Nash G.
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [Abstract] [Full Text] [Related]

  • 43. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O, Ropert M, Mosser A, Déhais V, Deugnier Y, David V, Brissot P, Jouanolle AM.
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [Abstract] [Full Text] [Related]

  • 44. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
    Viveiros A, Schaefer B, Panzer M, Henninger B, Plaikner M, Kremser C, Franke A, Franzenburg S, Hoeppner MP, Stauder R, Janecke A, Tilg H, Zoller H.
    Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
    [Abstract] [Full Text] [Related]

  • 45. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF, Carrasco M, Sardá MP, Barceló MJ, Baiget M.
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract] [Full Text] [Related]

  • 46. Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes.
    Pirisi M, Avellini C, Scott CA, Toniutto P, Intersimone D, Aprile G, Branca B, Fumo E.
    Adv Clin Path; 2001 Oct; 5(4):121-31. PubMed ID: 17582936
    [Abstract] [Full Text] [Related]

  • 47. Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants.
    Lv T, Zhang W, Xu A, Li Y, Zhou D, Zhang B, Li X, Zhao X, Wang Y, Wang X, Duan W, Wang Q, Xu H, Zheng J, Zhao R, Zhu L, Dong Y, Lu L, Chen Y, Long J, Zheng S, Wang W, You H, Jia J, Ou X, Huang J.
    J Med Genet; 2018 Oct; 55(10):650-660. PubMed ID: 30166352
    [Abstract] [Full Text] [Related]

  • 48. DNA testing for haemochromatosis: diagnostic, predictive and screening implications.
    Trent RJ, Le H, Yu B, Young G, Bowden DK.
    Pathology; 2000 Nov; 32(4):274-9. PubMed ID: 11186424
    [Abstract] [Full Text] [Related]

  • 49. Hereditary hemochromatosis.
    Fix OK, Kowdley KV.
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [Abstract] [Full Text] [Related]

  • 50. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP, Ramos P, de Almeida SF, Oliveira S, Breda L, Michalak M, Porto G, Rivella S, de Sousa M.
    Free Radic Biol Med; 2008 Jan 01; 44(1):99-108. PubMed ID: 18045552
    [Abstract] [Full Text] [Related]

  • 51. DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway.
    Li Y, Xu A, Ouyang Q, Zhang W, Zhang C, Chen Z, Zhou D, Zhang B, Duan W, Zhao X, Wang X, You H, Ou X, Jia J, Huang J.
    Hepatol Int; 2023 Jun 01; 17(3):648-661. PubMed ID: 36729283
    [Abstract] [Full Text] [Related]

  • 52. [Clinical and genetic aspects of hereditary hemochromatosis].
    Bosserhoff AK, Hellerbrand C, Buettner R.
    Pathologe; 2001 May 01; 22(3):191-6. PubMed ID: 11402849
    [Abstract] [Full Text] [Related]

  • 53. Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity.
    Papanikolaou G, Politou M, Terpos E, Fourlemadis S, Sakellaropoulos N, Loukopoulos D.
    Blood Cells Mol Dis; 2000 Apr 01; 26(2):163-8. PubMed ID: 11001626
    [Abstract] [Full Text] [Related]

  • 54. Clinical evaluation of a hemochromatosis next-generation sequencing gene panel.
    Lanktree MB, Sadikovic B, Waye JS, Levstik A, Lanktree BB, Yudin J, Crowther MA, Pare G, Adams PC.
    Eur J Haematol; 2017 Mar 01; 98(3):228-234. PubMed ID: 27753142
    [Abstract] [Full Text] [Related]

  • 55. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
    Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, Loreal O, Jouanolle AM, Brissot P.
    Clin Res Hepatol Gastroenterol; 2014 Apr 01; 38(2):143-54. PubMed ID: 24321703
    [Abstract] [Full Text] [Related]

  • 56. A novel homozygous stop-codon mutation in human HFE responsible for nonsense-mediated mRNA decay.
    Padula MC, Martelli G, Larocca M, Rossano R, Olivieri A.
    Blood Cells Mol Dis; 2014 Sep 01; 53(3):138-43. PubMed ID: 24920245
    [Abstract] [Full Text] [Related]

  • 57. Hereditary hemochromatosis: implications for South Dakota physicians.
    Stampe C, Weiland K.
    S D Med; 2013 Jan 01; 66(1):15, 17-8. PubMed ID: 23342715
    [Abstract] [Full Text] [Related]

  • 58. New Mutations in HFE2 and TFR2 Genes Causing Non HFE-Related Hereditary Hemochromatosis.
    Hernández G, Ferrer-Cortès X, Venturi V, Musri M, Pilquil MF, Torres PMM, Rodríguez IH, Mínguez MÀR, Kelleher NJ, Pelucchi S, Piperno A, Alberca EP, Ricós GG, Giró EC, Pérez-Montero S, Tornador C, Villà-Freixa J, Sánchez M.
    Genes (Basel); 2021 Dec 13; 12(12):. PubMed ID: 34946929
    [Abstract] [Full Text] [Related]

  • 59. Analysis of HFE and TFR2 gene mutations in patients with acute leukemia.
    Veneri D, Franchini M, Krampera M, de Matteis G, Solero P, Pizzolo G.
    Leuk Res; 2005 Jun 13; 29(6):661-4. PubMed ID: 15863206
    [Abstract] [Full Text] [Related]

  • 60. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N, National Hemochromatosis Transplant Registry.
    Gastroenterology; 2005 Aug 13; 129(2):494-503. PubMed ID: 16083706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.